Literature DB >> 9133992

Should heparin be reversed after carotid endarterectomy? A randomised prospective trial.

S J Fearn1, A D Parry, A J Picton, A J Mortimer, C N McCollum.   

Abstract

OBJECTIVE: To investigate whether heparin reversal after carotid endarterectomy reduces the incidence of haemorrhagic complications.
DESIGN: A randomised prospective trial.
METHODS: Sixty-four patients randomised to reversal of heparin or no reversal, of whom 31 received protamine titrated to the residual circulating heparin at closure of arteriotomy. Measurements included serial activated clotting times (ACTs), wound drainage, neck swelling using duplex Doppler imaging to measure the depth from skin to carotid bifurcation, and the recording of all complications.
RESULTS: Wound drainage volumes were significantly reduced by protamine reversal (68.5 ml compared to 35 ml, p < 0.001), but neck swelling was not (72 mm compared to 70 mm, p = 0.77). Two patients who were not reversed developed neck haematomas requiring evacuation. More importantly, two patients receiving protamine, thrombosed the operated internal carotid artery (ICA) postoperatively and died despite urgent thrombectomy. A further patient who was not randomised in this study but who received protamine also developed ICA thrombosis within the same 3 month period.
CONCLUSIONS: Reversing heparin with protamine reduces postoperative wound drainage after carotid surgery but may predispose to ICA thrombosis and stroke. This is in keeping with a previous retrospective study published during our trial.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133992     DOI: 10.1016/s1078-5884(97)80082-2

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  12 in total

1.  Shared quality data are associated with increased protamine use and reduced bleeding complications after carotid endarterectomy in the Vascular Study Group of New England.

Authors:  Reshma B Patel; Peter Beaulieu; Karen Homa; Philip P Goodney; Andrew C Stanley; Jack L Cronenwett; David H Stone; Daniel J Bertges
Journal:  J Vasc Surg       Date:  2013-09-05       Impact factor: 4.268

Review 2.  Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR).

Authors:  Abhishek Sharma; Sunny Goel; Carl J Lavie; Armin Arbab-Zadeh; Debabrata Mukherjee; Jason Lazar
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

3.  Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.

Authors:  Tamra Ranasinghe; Traci Mays; Jeff Quedado; Amelia Adcock
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-07-17       Impact factor: 2.136

4.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

5.  Haematomas after carotid endarterectomy can be reduced by direct pressure to the neck postoperatively.

Authors:  R Saghir; G Humm; T Rix
Journal:  Ann R Coll Surg Engl       Date:  2018-06-18       Impact factor: 1.891

6.  Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke.

Authors:  David H Stone; Brian W Nolan; Andres Schanzer; Philip P Goodney; Robert A Cambria; Donald S Likosky; Daniel B Walsh; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2010-01-04       Impact factor: 4.268

7.  Using protamine can significantly reduce the incidence of bleeding complications after carotid endarterectomy without increasing the risk of ischemic cerebral events.

Authors:  Franco Mazzalai; Giacomo Piatto; Antonio Toniato; Renata Lorenzetti; Claudio Baracchini; Enzo Ballotta
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

8.  Emergency reversal of antithrombotic treatment.

Authors:  Marcel Levi
Journal:  Intern Emerg Med       Date:  2008-11-12       Impact factor: 3.397

9.  Carotid Endarterectomy: experience in 8743 cases.

Authors:  R Chiesa; G Melissano; R Castellano; Y Tshomba; E M Marone; E Civilini; D Astore; F Calliari; B Catenaccio; G Coppi; A Carozzo; R Mennella
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2009

10.  Carotid endarterectomy at the millennium: what interventional therapy must match.

Authors:  Glenn M LaMuraglia; David C Brewster; Ashby C Moncure; David J Dorer; Michael C Stoner; Samir K Trehan; Elizabeth C Drummond; William M Abbott; Richard P Cambria
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.